comparemela.com

Brokerages expect Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Rating) to announce earnings per share (EPS) of ($0.02) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Ampio Pharmaceuticals’ earnings. Ampio Pharmaceuticals also posted earnings of ($0.02) per share in the same quarter last year. The firm is expected to […]

Related Keywords

United States , ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Get Rating ,Zacks Investment Research ,Ampio Pharmaceuticals Inc ,Get Rating ,Ampio Pharmaceutical ,Inhaled Ampion ,Respiratory Distress Due ,Nyse Ampe ,Ampe ,Medical ,Ratings ,Consensus ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.